Tag: <span>Anti-inflammatory therapy</span>

Home / Anti-inflammatory therapy
Post

Whole-body hyperthermia shows promising antidepressant effects through anti-inflammatory pathways

by Eric W. Dolan May 18, 2024in Depression New research provides preliminary evidence that whole-body hyperthermia may have antidepressant effects that operate through the activation of an anti-inflammatory immune signaling pathway. The findings have been published in the journal Brain, Behavior, and Immunity. Depression is a leading cause of disability worldwide and is expected to...

Muscling up with nanoparticle-based anti-inflammatory therapy
Post

Muscling up with nanoparticle-based anti-inflammatory therapy

by Benjamin Boettner,  Harvard University The images on top show representative muscle histology with increased muscle fiber area (pink) and improved morphology (fewer damaged fibers, white spaces) two weeks after mice with DMD were treated with a single dose of IL-4 NPs (PA4), compared to the PBS negative control. Scale bar, 300um. The images on the...

Anti-inflammatory therapy shows promise in slowing progression of multiple sclerosis
Post

Anti-inflammatory therapy shows promise in slowing progression of multiple sclerosis

by Adrianna MacPherson,  University of Alberta Faculty of Medicine & Dentistry U of A researcher Christopher Power and his team found that administering an anti-inflammatory drug called VX-765 through the nose slowed the progression of multiple sclerosis in a preclinical model. Intranasal administration of an anti-inflammatory drug helped reduce disease progression in a preclinical model of...

Post

Human immune ‘trigger’ map paves way for better treatments

A discovery about how human cells are ‘triggered’ to undergo an inflammatory type of cell death could have implications for treating cancer, stroke and tissue injury, and immune disorders. IMAGE: A DISCOVERY ABOUT HOW HUMAN CELLS ARE 'TRIGGERED' TO UNDERGO AN INFLAMMATORY TYPE OF CELL DEATH COULD HAVE IMPLICATIONS FOR TREATING CANCER, STROKE AND TISSUE INJURY,...

Post

Anti-inflammatory therapy cuts risk of lung cancer

In most clinical trials for cancer therapy, investigators test treatments in patients with advanced disease. But a recent cardiovascular secondary prevention study has given researchers a unique opportunity: to explore the effectiveness of giving a drug to patients before cancer emerges. At the European Society of Cardiology meeting, Paul M. Ridker, MD, director of the...

August 29, 2017August 29, 2017by In Cancer